Belite Bio, Inc (BLTE)
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, which is in the preclinical development phase. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.
$1.49B
Dr. Yu-Hsin Lin M.B.A., Ph.D.
12.00
San Diego, CA
Apr 29, 2022
-39.47
$-1.23
0.00
0.00
0.00%
-41.69
0.59
12.84
0.00
0.00
-29.80%
-39.84%
Similar stocks (16)
AnaptysBio, Inc.
ANAB
Celcuity Inc.
CELC
Entrada Therapeutics, Inc.
TRDA
Larimar Therapeutics, Inc.
LRMR
Monte Rosa Therapeutics, Inc.
GLUE
Acrivon Therapeutics, Inc. Common Stock
ACRV
Vigil Neuroscience, Inc.
VIGL
Ikena Oncology, Inc.
IKNA
PMV Pharmaceuticals, Inc.
PMVP
Immuneering Corporation
IMRX
Aligos Therapeutics, Inc.
ALGS
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
Aadi Bioscience, Inc.
AADI
AN2 Therapeutics, Inc.
ANTX
Galecto, Inc.
GLTO
ETF Exposure (3)
SPDR S&P Emerging Markets Small Cap ETF
EWX
0.039949%
SPDR S&P China ETF
GXC
0.02089%
SPDR Portfolio Emerging Markets ETF
SPEM
0.004913%
Similar stocks (16)
AnaptysBio, Inc.
ANAB
Celcuity Inc.
CELC
Entrada Therapeutics, Inc.
TRDA
Larimar Therapeutics, Inc.
LRMR
Monte Rosa Therapeutics, Inc.
GLUE
Acrivon Therapeutics, Inc. Common Stock
ACRV
Vigil Neuroscience, Inc.
VIGL
Ikena Oncology, Inc.
IKNA
PMV Pharmaceuticals, Inc.
PMVP
Immuneering Corporation
IMRX
Aligos Therapeutics, Inc.
ALGS
Aerovate Therapeutics, Inc.
AVTE
Anebulo Pharmaceuticals, Inc.
ANEB
Aadi Bioscience, Inc.
AADI
AN2 Therapeutics, Inc.
ANTX
Galecto, Inc.
GLTO
ETF Exposure (3)
SPDR S&P Emerging Markets Small Cap ETF
EWX
0.039949%
SPDR S&P China ETF
GXC
0.02089%
SPDR Portfolio Emerging Markets ETF
SPEM
0.004913%